Effectiveness of emicizumab in preventing bleeding events in hemophilia A patients: An observational study
Saved in:
Main Authors: | Nikhil Gupta (Author), Mousin Mustafa Batt (Author), Amit Saini (Author), Sanjeev Kumar Digra (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emicizumab in the treatment of hemophilia A
by: Tijanić Ivan R., et al.
Published: (2020) -
Budget Impact Analysis of the use of emicizumab for bleeding prophylaxis in patients with Hemophilia A with inhibitors in the Brazilian Health System
by: Nicolas Segre, et al.
Published: (2022) -
Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab
by: Hannah Glonnegger, et al.
Published: (2022) -
THE USE OF EMICIZUMAB IN A CHILD WITH HEMOPHILIA A INHIBITORY FOREMA
by: Юлия Олеговна Рождественская, et al.
Published: (2023) -
Management of children with hemophilia A on emicizumab who need surgery
by: Mark Belletrutti, et al.
Published: (2023)